PositoAI/ JP/ Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.

Tokyo: 4892 · Healthcare

Positivity Index

#8,084 / 10,750

Global

#3,374 / 3,683

Japan

Positivity Score

19,445

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: not checked yet

Cyfuse Biomedical K.K. — Overview & Financial Snapshot

Cyfuse Biomedical K.K. (Tokyo: 4892) is a Healthcare company, ranked #8,084 of 10,750 companies globally and #3,374 of 3,683 in Japan on PositoAI, with a Positivity Score of 19,445. Its market capitalisation is ₹344.57 Cr (¥5.69B), P/E ratio is -6.9 and P/B ratio is 2.17. Red flags (PosiRed) are not checked yet for companies in this market.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Wel-Dish.Incorporated 27,767 #19 Kohjin Bio Co., Ltd. 25,943 #40 MTI Ltd. 25,486 #49 GIMIC Co., Ltd. 25,357 #59 PhoenixBio Co., Ltd. 25,246

— Nothing to show —

OpenAI is reading recent news...

Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States. The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells. It also provides the Human 3D Mini-Liver, an in vitro MASH model that recapitulates human liver functions and predicts efficacy of drugs. Cyfuse Biomedical K.K. was incorporated in 2010 and is headquartered in Minato, Japan.

P/B Ratio 2.17

P/E Ratio -6.9

D/E Ratio 0.47

ROE -32.12%

Owes vs Owns ? 0.33× Low ¥0.33 owed for every ¥1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-49.26¥-81.38

Forward EPS —

Beta 1.27

Market Cap ₹344.57 Cr¥5.69B

What these numbers mean →

What does Cyfuse Biomedical K.K. do?

What is Cyfuse Biomedical K.K.'s P/E and P/B ratio?

Cyfuse Biomedical K.K. has a P/E ratio of -6.9 and a P/B ratio of 2.17.

What is Cyfuse Biomedical K.K.'s debt-to-equity ratio?

Cyfuse Biomedical K.K. has a debt-to-equity ratio of 0.47.

How much does Cyfuse Biomedical K.K. owe compared with what it owns?

Cyfuse Biomedical K.K. owes ¥0.33 for every ¥1 it owns (balance sheet Jun 2026), which is low.

What is Cyfuse Biomedical K.K.'s Positivity rank?

Cyfuse Biomedical K.K. is ranked #8,084 of 10,750 companies globally and #3,374 of 3,683 in Japan on PositoAI, with a Positivity Score of 19,445.

Does Cyfuse Biomedical K.K. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Cyfuse Biomedical K.K..

Where can I read the latest news about Cyfuse Biomedical K.K.?

Recent headlines about Cyfuse Biomedical K.K. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Cyfuse Biomedical K.K. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Cyfuse Biomedical K.K.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.